MedicarePartD.guide

A non-government resource built from CMS public data

Sleep drugs on every 2026 Nevada Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in Nevada cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Sleep drugs by 2026 Nevada Part D plan
DrugHumana Basic Rx Plan$0.00/moS5884-112Wellcare Classic$2.70/moS4802-093Wellcare Value Script$2.70/moS4802-161Humana Value Rx Plan$43.70/moS5884-208HealthSpring Extra Rx$52.60/moS5617-379AARP Medicare Rx Saver from UHC$76.70/moS5921-373HealthSpring Assurance Rx$95.60/moS5617-143SilverScript Choice$97.40/moS5601-058AARP Medicare Rx Preferred from UHC$139.10/moS5921-410Humana Premier Rx Plan$148.70/moS5884-175
zolpidemgeneric AmbienTier 2$1.00QL 30/30dTier 2$10.00QL 30/30dTier 2$3.00QL 30/30dTier 2$0.00QL 30/30dTier 2$5.00QL 30/30dTier 319%QL 30/30dTier 2$2.00QL 30/30dTier 2PA$7.00QL 30/30dTier 2$10.00QL 30/30dTier 2$4.00QL 30/30d
eszopiclonegeneric LunestaNot coveredNot coveredNot coveredTier 2$0.00QL 30/30dNot coveredNot coveredNot coveredNot coveredTier 318%QL 30/30dTier 2$4.00QL 30/30d
BelsomrasuvorexantTier 325%QL 60/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 318%QL 60/30dTier 430%QL 30/30dTier 319%QL 30/30dNot coveredNot coveredTier 318%QL 30/30dTier 3$45.00QL 60/30d
DayvigolemborexantNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredTier 430%QL 30/30dTier 318%QL 30/30dNot coveredNot covered
QuviviqdaridorexantNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredTier 436%QL 30/30dNot covered
doxepingeneric Silenor (low-dose tablets)Not coveredTier 431%QL 30/30dTier 325%QL 30/30dNot coveredTier 430%QL 30/30dNot coveredTier 430%QL 30/30dTier 318%QL 30/30dNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.